免疫疗法药物市场规模、占有率、趋势、行业分析报告（按类型、应用、给药途径、最终用户和地区）- 市场预测，2025-2034 年

根据Polaris Market Research的最新研究，全球免疫疗法市场规模预计到2034年将达到11,520.3亿美元。该报告提供了有关当前市场动态的详细见解，并对未来市场的成长进行了分析。

免疫疗法市场涉及开发、生产和销售利用人体免疫系统透过针对特定细胞或途径治疗疾病（尤其是癌症）的药物。与传统治疗相比，标靶治疗的应用越来越多，这极大地推动了免疫治疗药物市场的成长。标靶疗法，例如单株抗体，旨在专门攻击癌细胞或病原体，最大限度地减少对健康细胞的损害，并避免化疗等传统疗法中常见的副作用。向更精准、更有效的治疗转变与个人化医疗日益增长的需求相吻合，个人化医疗的治疗是根据遗传和疾病特征针对个别患者情况量身定制的。因此，预计预测期内免疫疗法药物市场的需求将扩大。

新免疫疗法药物的批准和不断扩大的应用正在进一步推动市场成长。例如，2024年4月，阿斯特捷利康和第一三共的Enhertu获得FDA批准，成为首个针对先前接受过治疗的转移性HER2阳性实体瘤的肿瘤靶向HER2治疗药物，是一种标靶免疫疗法，体现了解决方案的趋势。

这些进步正在改善治疗结果并帮助免疫疗法被广泛接受为肿瘤学和其他治疗领域的标准治疗选择。各种癌症等慢性病的发生率不断上升，预计将进一步推动这些创新治疗方法的需求，以巩固免疫疗法药物市场的扩张。

近年来，在医疗机构和倡导团体的支持下，人们对该病的认识不断提高，并提早发现，透过鼓励及时治疗，大大促进了免疫疗法市场的发展。这种积极主动的方法有望改善免疫疗法的效果。此外，合作和大量研发投资推动的生物技术进步正在推动免疫疗法解决方案的创新。透过扩大治疗选择和改善患者护理，它们正在推动市场成长。

免疫治疗药物市场报告重点

抗体药物在免疫疗法市场占据主导地位，因为它们透过精准标靶疗法在治疗癌症和自体免疫疾病方面被证明有效。

肿瘤学占免疫疗法市场的最大占有率，由于未满足的医疗需求很高且新疗法的疗效显着，因此预计肿瘤学将继续占据主导地位。

由于癌症发生率高、医疗保健体系强大、生物技术投资巨大以及新疗法迅速采用，预计北美将在 2024 年占据市场最大收入占有率。

由于医疗保健基础设施的进步、高疾病盛行率以及强大的临床试验和研究管道，亚太地区的免疫疗法药物市场预计将以最快的速度成长。

目录

第 1 章简介

第 2 章执行摘要

第 3 章 研究方法

第 4 章：全球免疫疗法药物市场洞察

• 市场概况
• 免疫治疗市场动态
  • 推动因素和机遇
    • 免疫疗法研发活动的进展
    • 免疫疗法联合疗法将推动市场成长
  • 阻碍因素和课题
    • 监理障碍与核准延迟
• PESTEL 分析
• 免疫治疗药物市场的应用趋势
• 价值链分析
• COVID-19 影响分析

第 5 章全球免疫疗法药物市场类型

• 主要发现
• 简介
• 抗体药物
• 抑制剂
• 干扰素和白血球介素
• 疫苗
• 其他

第 6 章全球免疫疗法药物市场（按应用）

• 主要发现
• 简介
• 癌症
• 自体免疫疾病与发炎性疾病
• 血液学
• 骨科
• 神经病学
• 其他

第 7 章依给药途径划分的全球免疫疗法市场

• 主要发现
• 简介
• 静脉注射
• 皮下
• 口服
• 其他

第 8 章 全球免疫疗法药物市场（依最终用户划分）

• 主要发现
• 简介
• 医院
• 长期照护机构
• 其他

第 9 章全球免疫治疗药物市场（按地区）

• 主要发现
• 简介
  • 2020 年至 2034 年各地区免疫疗法市场评估
• 北美洲
  2020 年至 2034 年北美各类型 2020 年至 2034 年北美各行政路线
  • 2020 年至 2034 年北美各应用领域
  • 2020 年至 2034 年，北美地区终端用户分布
  • 美国
  • 加拿大
• 欧洲
  2020 年至 2034 年欧洲各类型 欧洲，依给药途径，2020 年至 2034 年 2020 年至 2034 年欧洲应用状况 2020 年至 2034 年欧洲终端用户状况
  • 英国
  • 法国
  • 德国
  • 义大利
  • 西班牙
  • 荷兰
  • 俄罗斯
  • 其他欧洲国家
  亚太地区
  2020 年至 2034 年亚太地区各类产品 2020 年至 2034 年亚太地区行政路线分布 2020 年至 2034 年亚太地区应用状况 2020 年至 2034 年亚太地区最终用户状况
  • 中国
  • 印度
  • 马来西亚
  • 日本
  • 印尼
  • 韩国
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲
  2020 年至 2034 年中东和非洲各类型 2020 年至 2034 年按行政路线划分的中东和非洲 2020 年至 2034 年中东和非洲的应用状况 2020 年至 2034 年中东和非洲最终用户状况
  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 以色列
  • 南非
  • 其他中东和非洲地区
• 拉丁美洲
  2020 年至 2034 年拉丁美洲各类型
  • 2020 年至 2034 年拉丁美洲各行政路线状况
  • 2020 年至 2034 年拉丁美洲各应用领域状况 2020 年至 2034 年拉丁美洲最终用户状况
  • 墨西哥
  • 巴西
  • 阿根廷
  • 其他拉丁美洲国家

第 10 章 竞争格局

• 扩张与收购分析
  • 放大
  • 收购
• 伙伴关係/协作/协定/揭露

第 11 章 公司简介

• Abbvie Inc.
• Amgen Inc.
• AstraZeneca
• Bristol-Myers Squibb Company
• F. Hoffman-La Roche Ltd.
• Gilead Sciences, Inc.
• GSK PLC
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi
• Takeda Pharmaceutical Company Limited.
• Teva Pharmaceutical Industries Ltd.

The global immunotherapy drugs market size is expected to reach USD 1,152.03 billion by 2034, according to a new study by Polaris Market Research. The report "Immunotherapy Drugs Market Size, Share, Trends, Industry Analysis Report: By Type (Antibody Drugs, Inhibitor Drugs, Interferons and Interleukins, Vaccines, and Others), Application, Route of Administration, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025 - 2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The immunotherapy drugs market involves the development, production, and sale of medications that use the body's immune system to treat diseases, particularly cancer, by targeting specific cells or pathways. The rising adoption of targeted therapy over traditional treatment methods is significantly driving the immunotherapy drugs market growth. Targeted therapies, such as monoclonal antibodies, are designed to specifically attack cancer cells or pathogens, which minimizes damage to healthy cells and reduces side effects commonly associated with conventional treatments such as chemotherapy. This shift towards more precise and effective treatments aligns with the increasing demand for personalized medicine, which tailors therapies to individual patient profiles based on genetic and disease characteristics. As a result, the immunotherapy drugs market demand is projected to grow over the forecast period.

The approval of new immunotherapy drugs and the expansion of their applications are further propelling market growth. For instance, in April 2024, AstraZeneca and Daiichi Sankyo's Enhertu were approved by the FDA as the first tumor-agnostic HER2-directed therapy for previously treated metastatic HER2-positive solid tumors, exemplifying the trend toward targeted immunotherapy solutions.

These advancements enhance treatment efficacy and also contribute to a broader acceptance of immunotherapy as a standard care option in oncology and other therapeutic areas. The growing prevalence of chronic diseases, including various cancers, is expected to increase the demand for these innovative therapies further, solidifying the immunotherapy drugs market expansion.

In recent years, increasing awareness and earlier detection of diseases, supported by healthcare organizations and advocacy groups, have significantly enhanced the immunotherapy drugs market by encouraging timely treatment. This proactive approach allows for better outcomes with immunotherapies. Further, advancements in biotechnology driven by research collaborations and substantial investments in R&D are fostering innovation in immunotherapy solutions. Together, these are expanding treatment options and improving patient care, thereby propelling market growth.

Immunotherapy Drugs Market Report Highlights

The antibody drugs segment dominated the immunotherapy drugs market due to their proven efficacy in treating cancers and autoimmune diseases with targeted precision.

The cancer segment held the largest immunotherapy drugs market share and is expected to remain dominant due to high unmet medical needs and the promising results of new therapies.

North America region held the largest revenue share of the market in 2024 due to high cancer prevalence, a robust healthcare system, significant investments in biotechnology, and rapid adoption of new therapies.

The immunotherapy drugs market in Asia Pacific is expected to grow fastest due to advancements in healthcare infrastructure, high disease incidence, and a strong pipeline of clinical trials and research.

The global key market players include Abbvie Inc.; Amgen Inc.; AstraZeneca; Bristol-Myers Squibb Company; F. Hoffman-La Roche Ltd.; Gilead Sciences, Inc.; GSK PLC; Johnson & Johnson Services, Inc.; Merck & Co., Inc.; Novartis AG; Pfizer Inc.; Sanofi; and others.

Polaris Market Research has segmented the immunotherapy drugs market report based on type, application, route of administration, end user, and region:

By Type Outlook

§ Antibody Drugs

§ Inhibitor Drugs

§ Interferons and Interleukins

§ Vaccines

§ Others

By Application Outlook

§ Cancer

§ Autoimmune and Inflammatory Diseases

§ Hematology

§ Osteology

§ Neurology

§ Others

By Route of Administration Outlook

§ Intravenous

§ Subcutaneous

§ Oral

§ Others

By End User Outlook

§ Hospitals

§ Long-Term Care Facilities

§ Others

By Regional Outlook

North America

US

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Vietnam

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Mexico

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Immunotherapy Drugs Market Insights

• 4.1. Immunotherapy Drugs Market - Market Snapshot
• 4.2. Immunotherapy Drugs Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing Advancements in Immunotherapy Research & Development Activities
    • 4.2.1.2. Combination Therapies in Immunotherapy Drives Market Growth
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Regulatory Hurdles and Approval Delays
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Immunotherapy Drugs Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Immunotherapy Drugs Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
• 5.3. Antibody Drugs
  • 5.3.1. Global Immunotherapy Drugs Market, by Antibody Drugs, by Region, 2020-2034 (USD Billion)
• 5.4. Inhibitor Drugs
  • 5.4.1. Global Immunotherapy Drugs Market, by Inhibitor Drugs, by Region, 2020-2034 (USD Billion)
• 5.5. Interferons and Interleukins
  • 5.5.1. Global Immunotherapy Drugs Market, by Interferons and Interleukins, by Region, 2020-2034 (USD Billion)
• 5.6. Vaccines
  • 5.6.1. Global Immunotherapy Drugs Market, by Vaccines, by Region, 2020-2034 (USD Billion)
• 5.7. Other
  • 5.7.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Immunotherapy Drugs Market, by Application

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
• 6.3. Cancer
  • 6.3.1. Global Immunotherapy Drugs Market, by Cancer, by Region, 2020-2034 (USD Billion)
• 6.4. Autoimmune and Inflammatory Diseases
  • 6.4.1. Global Immunotherapy Drugs Market, by Autoimmune and Inflammatory Diseases, by Region, 2020-2034 (USD Billion)
• 6.5. Hematology
  • 6.5.1. Global Immunotherapy Drugs Market, by Hematology, by Region, 2020-2034 (USD Billion)
• 6.6. Osteology
  • 6.6.1. Global Immunotherapy Drugs Market, by Osteology, by Region, 2020-2034 (USD Billion)
• 6.7. Neurology
  • 6.7.1. Global Immunotherapy Drugs Market, by Neurology, by Region, 2020-2034 (USD Billion)
• 6.8. Other
  • 6.8.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

7. Global Immunotherapy Drugs Market, by Route of Administration

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
• 7.3. Intravenous
  • 7.3.1. Global Immunotherapy Drugs Market, by Intravenous, by Region, 2020-2034 (USD Billion)
• 7.4. Subcutaneous
  • 7.4.1. Global Immunotherapy Drugs Market, by Subcutaneous, by Region, 2020-2034 (USD Billion)
• 7.5. Oral
  • 7.5.1. Global Immunotherapy Drugs Market, by Oral, by Region, 2020-2034 (USD Billion)
• 7.6. Other
  • 7.6.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

8. Global Immunotherapy Drugs Market, by End-User

• 8.1. Key Findings
• 8.2. Introduction
  • 8.2.1. Global Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 8.3. Hospitals
  • 8.3.1. Global Immunotherapy Drugs Market, by Hospitals, by Region, 2020-2034 (USD Billion)
• 8.4. Long-Term Care Facilities
  • 8.4.1. Global Immunotherapy Drugs Market, by Long-Term Care Facilities, by Region, 2020-2034 (USD Billion)
• 8.5. Other
  • 8.5.1. Global Immunotherapy Drugs Market, by Other, by Region, 2020-2034 (USD Billion)

9. Global Immunotherapy Drugs Market, by Geography

• 9.1. Key Findings
• 9.2. Introduction
  • 9.2.1. Immunotherapy Drugs Market Assessment, By Geography, 2020-2034 (USD Billion)
• 9.3. Immunotherapy Drugs Market - North America
  • 9.3.1. North America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.3.2. North America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.3.3. North America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.3.4. North America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.3.5. Immunotherapy Drugs Market - U.S.
    • 9.3.5.1. U.S.: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.3.5.2. U.S.: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.5.3. U.S.: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.3.5.4. U.S.: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.3.6. Immunotherapy Drugs Market - Canada
    • 9.3.6.1. Canada: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.3.6.2. Canada: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.3.6.3. Canada: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.3.6.4. Canada: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.4. Immunotherapy Drugs Market - Europe
  • 9.4.1. Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.4.2. Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.4.3. Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.4.4. Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.5. Immunotherapy Drugs Market - UK
    • 9.4.5.1. UK: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.5.2. UK: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.5.3. UK: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.5.4. UK: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.6. Immunotherapy Drugs Market - France
    • 9.4.6.1. France: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.6.2. France: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.6.3. France: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.6.4. France: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.7. Immunotherapy Drugs Market - Germany
    • 9.4.7.1. Germany: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.7.2. Germany: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.7.3. Germany: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.7.4. Germany: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.8. Immunotherapy Drugs Market - Italy
    • 9.4.8.1. Italy: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.8.2. Italy: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.8.3. Italy: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.8.4. Italy: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.9. Immunotherapy Drugs Market - Spain
    • 9.4.9.1. Spain: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.9.2. Spain: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.9.3. Spain: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.9.4. Spain: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.10. Immunotherapy Drugs Market - Netherlands
    • 9.4.10.1. Netherlands: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.10.2. Netherlands: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.10.3. Netherlands: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.10.4. Netherlands: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.11. Immunotherapy Drugs Market - Russia
    • 9.4.11.1. Russia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.11.2. Russia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.11.3. Russia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.11.4. Russia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.4.12. Immunotherapy Drugs Market - Rest of Europe
    • 9.4.12.1. Rest of Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.4.12.2. Rest of Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.4.12.3. Rest of Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.4.12.4. Rest of Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.5. Immunotherapy Drugs Market - Asia Pacific
  • 9.5.1. Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.5.2. Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.5.3. Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.5.4. Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.5. Immunotherapy Drugs Market - China
    • 9.5.5.1. China: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.5.2. China: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.5.3. China: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.5.4. China: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.6. Immunotherapy Drugs Market - India
    • 9.5.6.1. India: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.6.2. India: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.6.3. India: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.6.4. India: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.7. Immunotherapy Drugs Market - Malaysia
    • 9.5.7.1. Malaysia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.7.2. Malaysia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.7.3. Malaysia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.7.4. Malaysia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.8. Immunotherapy Drugs Market - Japan
    • 9.5.8.1. Japan: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.8.2. Japan: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.8.3. Japan: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.8.4. Japan: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.9. Immunotherapy Drugs Market - Indonesia
    • 9.5.9.1. Indonesia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.9.2. Indonesia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.9.3. Indonesia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.9.4. Indonesia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.10. Immunotherapy Drugs Market - South Korea
    • 9.5.10.1. South Korea: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.10.2. South Korea: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.10.3. South Korea: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.10.4. South Korea: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.11. Immunotherapy Drugs Market - Australia
    • 9.5.11.1. Australia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.11.2. Australia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.11.3. Australia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.11.4. Australia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.5.12. Immunotherapy Drugs Market - Rest of Asia Pacific
    • 9.5.12.1. Rest of Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.5.12.2. Rest of Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.5.12.3. Rest of Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.5.12.4. Rest of Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.6. Immunotherapy Drugs Market - Middle East & Africa
  • 9.6.1. Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.6.2. Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.6.3. Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.6.4. Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.5. Immunotherapy Drugs Market - Saudi Arabia
    • 9.6.5.1. Saudi Arabia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.5.2. Saudi Arabia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.5.3. Saudi Arabia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.5.4. Saudi Arabia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.6. Immunotherapy Drugs Market - UAE
    • 9.6.6.1. UAE: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.6.2. UAE: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.6.3. UAE: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.6.4. UAE: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.7. Immunotherapy Drugs Market - Israel
    • 9.6.7.1. Israel: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.7.2. Israel: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.7.3. Israel: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.7.4. Israel: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.8. Immunotherapy Drugs Market - South Africa
    • 9.6.8.1. South Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.8.2. South Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.8.3. South Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.8.4. South Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.6.9. Immunotherapy Drugs Market - Rest of Middle East & Africa
    • 9.6.9.1. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.6.9.2. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.6.9.3. Rest of Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.6.9.4. Rest of Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
• 9.7. Immunotherapy Drugs Market - Latin America
  • 9.7.1. Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
  • 9.7.2. Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
  • 9.7.3. Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
  • 9.7.4. Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.5. Immunotherapy Drugs Market - Mexico
    • 9.7.5.1. Mexico: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.5.2. Mexico: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.5.3. Mexico: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.5.4. Mexico: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.6. Immunotherapy Drugs Market - Brazil
    • 9.7.6.1. Brazil: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.6.2. Brazil: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.6.3. Brazil: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.6.4. Brazil: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.7. Immunotherapy Drugs Market - Argentina
    • 9.7.7.1. Argentina: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.7.2. Argentina: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.7.3. Argentina: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.7.4. Argentina: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)
  • 9.7.8. Immunotherapy Drugs Market - Rest of Latin America
    • 9.7.8.1. Rest of Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)
    • 9.7.8.2. Rest of Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)
    • 9.7.8.3. Rest of Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)
    • 9.7.8.4. Rest of Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

10. Competitive Landscape

• 10.1. Expansion and Acquisition Analysis
  • 10.1.1. Expansion
  • 10.1.2. Acquisitions
• 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

• 11.1. Abbvie Inc.
  • 11.1.1. Company Overview
  • 11.1.2. Financial Performance
  • 11.1.3. Product Benchmarking
  • 11.1.4. Recent Development
• 11.2. Amgen Inc.
  • 11.2.1. Company Overview
  • 11.2.2. Financial Performance
  • 11.2.3. Product Benchmarking
  • 11.2.4. Recent Development
• 11.3. AstraZeneca
  • 11.3.1. Company Overview
  • 11.3.2. Financial Performance
  • 11.3.3. Product Benchmarking
  • 11.3.4. Recent Development
• 11.4. Bristol-Myers Squibb Company
  • 11.4.1. Company Overview
  • 11.4.2. Financial Performance
  • 11.4.3. Product Benchmarking
  • 11.4.4. Recent Development
• 11.5. F. Hoffman-La Roche Ltd.
  • 11.5.1. Company Overview
  • 11.5.2. Financial Performance
  • 11.5.3. Product Benchmarking
  • 11.5.4. Recent Development
• 11.6. Gilead Sciences, Inc.
  • 11.6.1. Company Overview
  • 11.6.2. Financial Performance
  • 11.6.3. Product Benchmarking
  • 11.6.4. Recent Development
• 11.7. GSK PLC
  • 11.7.1. Company Overview
  • 11.7.2. Financial Performance
  • 11.7.3. Product Benchmarking
  • 11.7.4. Recent Development
• 11.8. Johnson & Johnson Services, Inc.
  • 11.8.1. Company Overview
  • 11.8.2. Financial Performance
  • 11.8.3. Product Benchmarking
  • 11.8.4. Recent Development
• 11.9. Merck & Co., Inc.
  • 11.9.1. Company Overview
  • 11.9.2. Financial Performance
  • 11.9.3. Product Benchmarking
  • 11.9.4. Recent Development
• 11.10. Novartis AG
  • 11.10.1. Company Overview
  • 11.10.2. Financial Performance
  • 11.10.3. Product Benchmarking
  • 11.10.4. Recent Development
• 11.11. Pfizer Inc.
  • 11.11.1. Company Overview
  • 11.11.2. Financial Performance
  • 11.11.3. Product Benchmarking
  • 11.11.4. Recent Development
• 11.12. Sanofi
  • 11.12.1. Company Overview
  • 11.12.2. Financial Performance
  • 11.12.3. Product Benchmarking
  • 11.12.4. Recent Development
• 11.13. Takeda Pharmaceutical Company Limited.
  • 11.13.1. Company Overview
  • 11.13.2. Financial Performance
  • 11.13.3. Product Benchmarking
  • 11.13.4. Recent Development
• 11.14. Teva Pharmaceutical Industries Ltd.
  • 11.14.1. Company Overview
  • 11.14.2. Financial Performance
  • 11.14.3. Product Benchmarking
  • 11.14.4. Recent Development

List of Tables:

Table 1 Global Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 2 Global Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 3 Global Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 4 Global Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 5 North America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 6 North America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 7 North America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 8 North America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 9 U.S.: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 10 U.S.: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 11 U.S.: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 12 U.S.: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 13 Canada: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 14 Canada: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 15 Canada: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 16 Canada: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 17 Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 18 Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 19 Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 20 Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 21 UK: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 22 UK: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 23 UK: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 24 UK: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 25 France: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 26 France: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 27 France: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 28 France: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 29 Germany: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 30 Germany: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 31 Germany: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 32 Germany: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 33 Italy: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 34 Italy: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 35 Italy: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 36 Italy: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 37 Spain: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 38 Spain: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 39 Spain: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 40 Spain: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 41 Netherlands: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 42 Netherlands: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 43 Netherlands: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 44 Netherlands: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 45 Russia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 46 Russia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 47 Russia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 48 Russia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 49 Rest of Europe: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 50 Rest of Europe: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 51 Rest of Europe: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 52 Rest of Europe: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 53 Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 54 Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 55 Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 56 Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 57 China: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 58 China: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 59 China: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 60 China: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 61 India: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 62 India: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 63 India: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 64 India: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 65 Malaysia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 66 Malaysia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 67 Malaysia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 68 Malaysia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 69 Japan: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 70 Japan: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 71 Japan: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 72 Japan: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 73 Indonesia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 74 Indonesia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 75 Indonesia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 76 Indonesia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 77 South Korea: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 78 South Korea: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 79 South Korea: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 80 South Korea: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 81 Australia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 82 Australia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 83 Australia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 84 Australia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 85 Rest of Asia Pacific: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 86 Rest of Asia Pacific: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 87 Rest of Asia Pacific: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 88 Rest of Asia Pacific: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 89 Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 90 Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 91 Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 92 Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 93 Saudi Arabia: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 94 Saudi Arabia: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 95 Saudi Arabia: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 96 Saudi Arabia: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 97 UAE: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 98 UAE: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 99 UAE: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 100 UAE: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 101 Israel: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 102 Israel: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 103 Israel: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 104 Israel: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 105 South Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 106 South Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 107 South Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 108 South Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 109 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 110 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 111 Rest of Middle East & Africa: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 112 Rest of Middle East & Africa: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 113 Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 114 Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 115 Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 116 Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 117 Mexico: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 118 Mexico: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 119 Mexico: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 120 Mexico: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 121 Brazil: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 122 Brazil: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 123 Brazil: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 124 Brazil: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 125 Argentina: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 126 Argentina: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 127 Argentina: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 128 Argentina: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

Table 129 Rest of Latin America: Immunotherapy Drugs Market, by Type, 2020-2034 (USD Billion)

Table 130 Rest of Latin America: Immunotherapy Drugs Market, by Route of Administration, 2020-2034 (USD Billion)

Table 131 Rest of Latin America: Immunotherapy Drugs Market, by Application, 2020-2034 (USD Billion)

Table 132 Rest of Latin America: Immunotherapy Drugs Market, by End-User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Immunotherapy Drugs Market, 2020-2034 (USD Billion)

Figure 2. Integrated Ecosystem

Figure 3. Research Methodology: Top-Down & Bottom-Up Approach

Figure 4. Market by Geography

Figure 5. Porter's Five Forces

Figure 6. Market by Type

Figure 7. Global Immunotherapy Drugs Market, by Type, 2024 & 2034 (USD Billion)

Figure 8. Market by Route of Administration

Figure 9. Global Immunotherapy Drugs Market, by Route of Administration, 2024 & 2034 (USD Billion)

Figure 10. Market by Application

Figure 11. Global Immunotherapy Drugs Market, by Application, 2024 & 2034 (USD Billion)

Figure 12. Market by End-User

Figure 13. Global Immunotherapy Drugs Market, by End-User, 2024 & 2034 (USD Billion)